Literature DB >> 26240947

Melena as presentation of primary small intestine inflammatory myofibroblastic tumor in an adult woman. A case report.

Rossana Alloni, Gianluca Ancona, Ida Gallo, Anna Crescenzi, Roberto Coppola.   

Abstract

INTRODUCTION: Inflammatory myofibroblastic tumor (IMT), also known as inflammatory pseudotumor, plasma cell granuloma or inflammatory myofibroblastoma, is characterized histopathologically by myofibroblastic spindle cells with inflammatory cell infiltrates ( plasma cell, lymphocytes and eosinophils). Inflammatory myofibroblastic tumor is tipically seen in children or young adults and is most commonly localized in the lung, but it can occur anywhere in the body. CASE REPORT: We present a case in a young woman with severe acute G.I. bleeding, an uncommon presentation of IMT in adults. The patient was admitted to the emergency department for melena. MRI showed a distal jejunum hypervascular mass. Other exams were negative. Surgical excision was recommended, so the patient underwent surgery with complete removal of the tumoral mass. No adjuvant therapy was employed and the patient is asymptomatic after 6 months of follow-up. DISCUSSION: IMT is an rare lesion that mimics malignancy and is accompanied by various clinical manifestations. The treatment of choice is believed to be complete surgical excision and long term follow up. KEY WORDS: Anemia, Inflammatory myofibroblastic tumor (IMT), Small intestine, Surgery.

Entities:  

Mesh:

Year:  2015        PMID: 26240947

Source DB:  PubMed          Journal:  Ann Ital Chir        ISSN: 0003-469X            Impact factor:   0.766


  2 in total

1.  Polypoid Carcinoma of the Oropharynx with Stromal Ossifying Myofibroblastic Proliferation: A Case Report and Literature Review.

Authors:  Marcello Filotico; Alessandro D'Amuri
Journal:  Case Rep Pathol       Date:  2016-12-05

2.  Rare cases of pulmonary inflammatory myofibroblastic tumors in adult male patients: a case report.

Authors:  Hui Li; Yanfa He; Bin Wang; Xinliang Song; Dawei Zhao; Hang Yu; Kelei Qi; Tao Liu
Journal:  Transl Cancer Res       Date:  2021-09       Impact factor: 1.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.